August 31, 2016 10:48 AM ET

Pharmaceuticals

Company Overview of Actavis Pharma, Inc.

Key Executives for Actavis Pharma, Inc.

NameBoard RelationshipsTitleAge
Allen Chao Ph.D.36 RelationshipsChairman and Chief Executive Officer70

Actavis Pharma, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Allen Chao Ph.D. 36 RelationshipsActavis Pharma, Inc.70
Harvey Rosenthal 21 RelationshipsRea & Derick Inc73
Judith A. Hemberger Ph.D. 63 RelationshipsAVAX Technologies Inc.69
Michael J. Fedida 13 RelationshipsMystic Pharmaceuticals, Inc.69
Joseph A. Akers 64 RelationshipsBayer Corporation70
View All Board Members

Actavis Pharma, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
424.6K
Bonus
535.0K
Total Short Term Compensation
626.3K
Total Value of Options
14.6M
Compensation as of Fiscal Year
Actavis Pharma, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Sagent Pharmaceuticals, Inc. Announces Cessation of Board of Directors
August 29, 2016 8:17 PM ET
Nabriva Therapeutics AG Announces Executive Appointments
August 29, 2016 2:09 PM ET
Innovus Pharmaceuticals, Inc. Announces Executive Changes, Effective September 6, 2016
August 29, 2016 10:01 AM ET
Novogen Ltd. Announces Executive Changes
August 29, 2016 12:28 AM ET
Abbot Laboatories (Pakistan) Ltd. Announces Change in Director
August 29, 2016 12:00 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Actavis Pharma, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.